(Q39686421)

English

Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection

scientific article published on May 1987

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

Phase I and II agents in cancer therapy: two cisplatin analogues and high-dose cisplatin in hypertonic saline or with thiosulfate protection (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

based on heuristic

inferred from title

Peter H. Wiernik

3

object named as

Wiernik PH

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Fuks JZ

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wadler S

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1987

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

357-365

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

The Role of cis-Platinum in Solid-Tumor Therapy

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Drugs five years later. Cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Preclinical studies on toxicity, antitumour activity and pharmacokinetics of cisplatin and three recently developed derivatives.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Ovarian trials at the Royal Marsden.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

cis-Diammine-1, 1-cyclobutane dicarboxylate platinum II (carboplatin) in the treatment of testicular germ-cell tumours: a preliminary report.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

High-dose platinum for the treatment of refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

High-dose cisplatin with sodium thiosulfate protection.

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Synthesis and antitumor activity of new platinum complexes

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1987.TB03031.X

21 January 2018

Identifiers

10.1002/J.1552-4604.1987.TB03031.X

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39686421&oldid=1856371422"